Announced Thu, 25 Jun · 11:03 IST
Trading window closed from July 1, 2026 for Q1 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹7.51
prior close
₹7.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0-4.4+2.7-4.3-1.5-1.1-6.5-5.9-5.9——
Up moveDown movePending
AI summary
Vista Pharmaceuticals has closed its trading window from July 1, 2026 until 48 hours after the Board declares unaudited financial results for the quarter ending June 30, 2026. Designated persons and their immediate relatives cannot trade in company shares during this closed period. This is a routine compliance filing under SEBI insider trading regulations. The Board meeting date to approve the Q1 results will be announced later.
Likely market impact
Routine compliance filing. No direct impact on shareholders. Indicates Q1 FY27 results are approaching.